エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/11 | 8,893 | 9,031 | 8,833 | 8,991 | +111 | +1.3% | 1,259,500 |
2023/09/08 | 8,979 | 9,007 | 8,880 | 8,880 | -116 | -1.3% | 1,568,800 |
2023/09/07 | 9,088 | 9,112 | 8,981 | 8,996 | -87 | -1% | 973,500 |
2023/09/06 | 9,090 | 9,119 | 9,053 | 9,083 | -24 | -0.3% | 578,900 |
2023/09/05 | 9,047 | 9,117 | 9,041 | 9,107 | +38 | +0.4% | 858,500 |
2023/09/04 | 9,121 | 9,136 | 9,045 | 9,069 | -52 | -0.6% | 928,500 |
2023/09/01 | 9,194 | 9,199 | 9,102 | 9,121 | -137 | -1.5% | 1,122,400 |
2023/08/31 | 9,118 | 9,275 | 9,091 | 9,258 | +166 | +1.8% | 1,666,600 |
2023/08/30 | 9,100 | 9,182 | 9,073 | 9,092 | -14 | -0.2% | 1,061,700 |
2023/08/29 | 9,146 | 9,260 | 9,077 | 9,106 | +29 | +0.3% | 1,523,200 |
2023/08/28 | 9,119 | 9,140 | 9,047 | 9,077 | -23 | -0.3% | 1,076,400 |
2023/08/25 | 9,129 | 9,149 | 9,069 | 9,100 | -113 | -1.2% | 1,291,800 |
2023/08/24 | 9,210 | 9,297 | 9,190 | 9,213 | +13 | +0.1% | 1,234,500 |
2023/08/23 | 9,166 | 9,250 | 9,046 | 9,200 | +14 | +0.2% | 2,225,500 |
2023/08/22 | 9,495 | 9,540 | 9,153 | 9,186 | -159 | -1.7% | 5,371,100 |
2023/08/21 | 9,343 | 9,415 | 9,245 | 9,345 | +103 | +1.1% | 951,400 |
2023/08/18 | 9,159 | 9,338 | 9,141 | 9,242 | -7 | -0.1% | 774,700 |
2023/08/17 | 9,303 | 9,303 | 9,141 | 9,249 | -105 | -1.1% | 1,026,900 |
2023/08/16 | 9,473 | 9,481 | 9,303 | 9,354 | -181 | -1.9% | 1,027,100 |
2023/08/15 | 9,600 | 9,610 | 9,473 | 9,535 | -17 | -0.2% | 853,500 |
2023/08/14 | 9,530 | 9,614 | 9,525 | 9,552 | +46 | +0.5% | 1,107,700 |
2023/08/10 | 9,385 | 9,515 | 9,381 | 9,506 | +48 | +0.5% | 1,103,500 |
2023/08/09 | 9,380 | 9,497 | 9,366 | 9,458 | +131 | +1.4% | 1,363,100 |
2023/08/08 | 9,190 | 9,329 | 9,153 | 9,327 | +185 | +2% | 1,160,100 |
2023/08/07 | 8,941 | 9,170 | 8,927 | 9,142 | +151 | +1.7% | 815,800 |
2023/08/04 | 8,999 | 9,014 | 8,873 | 8,991 | -118 | -1.3% | 1,054,700 |
2023/08/03 | 9,180 | 9,214 | 9,026 | 9,109 | -68 | -0.7% | 1,773,900 |
2023/08/02 | 9,110 | 9,178 | 8,934 | 9,177 | +21 | +0.2% | 2,554,300 |
2023/08/01 | 9,069 | 9,162 | 9,042 | 9,156 | +180 | +2% | 1,368,100 |
2023/07/31 | 9,092 | 9,164 | 8,944 | 8,976 | +5 | +0.1% | 1,581,300 |
2023/07/28 | 8,860 | 8,996 | 8,746 | 8,971 | +27 | +0.3% | 1,926,800 |
2023/07/27 | 8,884 | 8,964 | 8,851 | 8,944 | +11 | +0.1% | 1,287,900 |
2023/07/26 | 8,930 | 8,974 | 8,882 | 8,933 | -61 | -0.7% | 1,145,600 |
2023/07/25 | 9,080 | 9,095 | 8,935 | 8,994 | -110 | -1.2% | 1,149,300 |
2023/07/24 | 9,120 | 9,152 | 9,051 | 9,104 | +72 | +0.8% | 1,051,900 |
2023/07/21 | 9,135 | 9,171 | 9,005 | 9,032 | -53 | -0.6% | 1,367,300 |
2023/07/20 | 9,060 | 9,146 | 8,980 | 9,085 | -95 | -1% | 1,477,000 |
2023/07/19 | 9,072 | 9,204 | 9,044 | 9,180 | +188 | +2.1% | 2,069,500 |
2023/07/18 | 8,800 | 9,019 | 8,777 | 8,992 | +244 | +2.8% | 2,150,000 |
2023/07/14 | 8,770 | 8,850 | 8,674 | 8,748 | +59 | +0.7% | 2,125,900 |
2023/07/13 | 8,490 | 8,708 | 8,480 | 8,689 | +205 | +2.4% | 2,627,200 |
2023/07/12 | 8,710 | 8,783 | 8,472 | 8,484 | -366 | -4.1% | 4,979,700 |
2023/07/11 | 9,174 | 9,274 | 8,830 | 8,850 | -397 | -4.3% | 4,789,900 |
2023/07/10 | 9,440 | 9,610 | 9,195 | 9,247 | -135 | -1.4% | 5,598,500 |
2023/07/07 | 9,889 | 9,917 | 9,044 | 9,382 | -460 | -4.7% | 12,279,600 |
2023/07/06 | 9,947 | 10,010 | 9,822 | 9,842 | -60 | -0.6% | 1,839,000 |
2023/07/05 | 9,671 | 10,015 | 9,654 | 9,902 | +128 | +1.3% | 1,699,000 |
2023/07/04 | 9,809 | 9,844 | 9,620 | 9,774 | -82 | -0.8% | 1,415,900 |
2023/07/03 | 9,819 | 9,907 | 9,815 | 9,856 | +132 | +1.4% | 1,369,200 |
2023/06/30 | 9,692 | 9,739 | 9,613 | 9,724 | -6 | -0.1% | 1,419,100 |
401~
450
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム